AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth Care
Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesTransplantation ConditioningAnemia, AplasticHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationCombined Modality TherapyRecurrenceHematopoiesisTreatment OutcomeMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationRemission InductionTime FactorsImmunosuppressive AgentsHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionStem Cell TransplantationImmunosuppressionLymphocyte DepletionLymphoma, Non-HodgkinLeukocyte TransfusionSurvival AnalysisAcute DiseaseHeart TransplantationRetrospective StudiesSevere Combined ImmunodeficiencyT-LymphocytesMyelodysplastic SyndromesChimeraColony-Forming Units AssayHLA AntigensActuarial AnalysisLung TransplantationHematologic DiseasesSurvival RateAntineoplastic Combined Chemotherapy ProtocolsCyclosporineBone DensityFollow-Up StudiesLymphocyte TransfusionNuclear FamilyCarmustineGraft vs Tumor EffectDisease-Free SurvivalOrgan TransplantationPancytopeniaCell DifferentiationGraft vs Leukemia EffectCytarabineLeukocyte CountPrognosisCytomegalovirus InfectionsSpleenGranulocyte Colony-Stimulating FactorMice, Inbred BALB CBone ResorptionMelphalanEtoposideLymphomaFlow CytometryMultiple MyelomaFatal OutcomeCells, CulturedHodgkin DiseaseAntigens, CD34InfectionMice, KnockoutCell TransplantationGranulocytesCord Blood Stem Cell Transplantation
Allogeneic hematopoietic stem cPotentiallyBring the curative powerDamaged bone marrow with healthyDonorSickleOncologyComplicationsAcuteBiopsyTreatmentHematopoietic cell transplantationTherapeuticPeripheral bloodSevereHSCTPlateletsCytopeniasDisordersCord bloodMyelodysplasticAbnormalBlood and marrowLymph nodesClinicalHematologicalLymphomaDiagnosisAspirationTransplantsPatient'sMalignant and non-malignantRelapseDiseasesMutationsMalignancies2016SpleenRegimensMyelofibrosisTransplant centerAbnormalitiesPrognosticReliablyThrombosisAnemiaRemissionCancerSymptomsTherapyLaboratoryTreatmentsStem cellReticulin100,000CellsSurvival
Allogeneic hematopoietic stem c7
Potentially10
  • This pivotal prospective study demonstrates that allogeneic HCT represents an important, potentially curative, therapeutic strategy in patients with high-risk genetic sub-groups of MDS, including patients with TP53 mutated MDS," Journal of Clinical Oncology associated editor Dr. Charles F. Craddock of Queen Elizabeth Hospital in Birmingham, England wrote in a contextual commentary published along with the study. (curetoday.com)
  • At Gamida Cell, we are at the forefront of developing and commercializing potentially curative medicines for patients by harnessing our proprietary NAM cell expansion technology. (seekingalpha.com)
  • The only potentially curative therapies currently available for severe alpha-thalassemia are bone marrow transplantation and gene therapy, both of which have significant limitations for widespread use. (ox.ac.uk)
  • Autologous bone marrow transplantation (ABMT), whereby the patient's own marrow is used as the source of stem cell rescue, is potentially curative in patients with acute myeloid leukemia (AML). (arizona.edu)
  • Allogeneic haemopoietic stem cell transplantation offers a potentially curative treatment option for a wide range of life-threatening malignant and non-malignant disorders of the bone marrow and immune system in patients of all ages. (nih.gov)
  • Intellia's in vivo platform technology delivers CRISPR/Cas9 intravenously, potentially avoiding the need for bone marrow transplantation surgery. (newswise.com)
  • Intellia Therapeutics is a leading genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. (newswise.com)
  • The use of salicylates as a tonic against thrombosis in PV patients is not only potentially harmful if the red cell mass is not controlled by phlebotomy, but is also an unproven remedy. (basicmedicalkey.com)
  • Hematopoietic cell transplantation (HCT) for sickle cell disease (SCD) is potentially curative, yet applied sparingly in adults due in part to limited donor availability and to concerns about safety. (ashpublications.org)
  • Hematopoietic stem cell transplantation is the only potentially curative therapy, but it is only an option for select patients. (cancernetwork.com)
Bring the curative power2
  • As we seek to bring the curative power of cell therapies to a greater number of patients suffering from otherwise incurable life-threatening diseases, we are very confident in Prevail InfoWorks' ability to coordinate our Phase I clinical trial in relapsed/refractory AML. (wate.com)
  • The Company is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. (sanfranciscostar.com)
Damaged bone marrow with healthy1
Donor18
  • 15% of patients with SCD have an HLA-matched sibling donor. (nih.gov)
  • And even when a bone marrow transplant is curative for leukemia or lymphoma, GVHD-in which T cells in the donor graft attack the recipient's own tissues-can still be fatal. (genengnews.com)
  • Allogeneic HCT confers superior survival in transplant-eligible patients with high-risk MDS and an available donor. (curetoday.com)
  • For an allogeneic stem cell transplant , after the bone marrow is destroyed, the patient receives blood-forming stem cells from another person - the donor," the American Cancer Society explained. (curetoday.com)
  • Among the 309 participants in the recent study there was a similar distribution of genetic mutations between the 229 patients who received HCT (the donor arm) and the 80 who did not (the non-donor arm): TP53 (28% vs. 29%), ASXL1 (23% vs. 29%) and SRSF2 (16% vs. 16%) were the most common genetic mutations. (curetoday.com)
  • Likewise, OS at three years was 68% among patients with very high risk IPSS (IPSS-M) without a TP53 mutation in the donor arm was 68%, but 0% for patients in the non-donor arm. (curetoday.com)
  • A 63-year-old man with adult T-cell leukemia-lymphoma underwent allogeneic bone marrow transplantation from an HLA-matched unrelated donor. (bvsalud.org)
  • The Allogeneic bone-marrow transplantation represents the only curative treatment and requires a compatible donor HLA. (longdom.org)
  • We initially search a potential donor within the siblings of the patient by determining HLA type, true genetic identity card of the cells. (longdom.org)
  • This global trial evaluated omidubicel versus standard cord blood in patients with hematologic malignancies, who needed a bone marrow transplant, but did not have a suitable match donor. (seekingalpha.com)
  • Unfortunately, most patients with SCD do not have a suitable human lymphocyte antigen-matched sibling donor. (johnshopkins.edu)
  • Summary The curative potential of BMT in SCD is irrefutable, with outstanding results in children following a myeloablative conditioning regimen and a matched sibling donor transplant. (johnshopkins.edu)
  • With rapidly emerging advances in the use of alternative donors, such as mismatched unrelated, cord blood and haploidentical donors, it is now possible to find a potential donor for almost all patients in whom an allograft is indicated. (nih.gov)
  • Therefore, for any specific patient, the transplant physician may be faced with a myriad of potential choices, including decisions concerning which donor to prioritize where there is more than one, the optimal selection of specific umbilical cord blood units and which conditioning and graft-versus-host disease prophylactic schedule to use. (nih.gov)
  • Donor choice may be further complicated by other important factors, such as urgency of transplant, the presence of alloantibodies, the disease status (homozygosity or heterozygosity) of sibling donors affected by inherited disorders and the cytomegalovirus serostatus of patient and donor. (nih.gov)
  • We report UK consensus guidelines on the selection of umbilical cord blood units, the hierarchy of donor selection and the preferred conditioning regimens for umbilical cord blood transplantation, with a summary of rationale supporting these recommendations. (nih.gov)
  • Donor stem cells are used in allogeneic stem cell transplantation. (bonemarrowtransplantations.com)
  • Patients received unmodified bone marrow from a human leukocyte antigen (HLA)-matched sibling or an unrelated donor matched for 8 of 8 HLA loci. (ashpublications.org)
Sickle6
  • He has special interests in curative bone marrow and stem cell transplantation therapies, immunotherapies and gene editing for sickle cell disease. (atriumhealth.org)
  • Bolaños-Meade, J & Brodsky, RA 2009, ' Blood and marrow transplantation for sickle cell disease: Overcoming barriers to success ', Current opinion in oncology , vol. 21, no. 2, pp. 158-161. (johnshopkins.edu)
  • The disease is present in a patient who has received two copies of the defective gene from their parents leading to the production of non-functional hemoglobin S involved in sickle cell anemia, instead of healthy hemoglobin A. It is autosomal recessive transmission (affecting both girls and boys) recessive. (carenity.co.uk)
  • Simply put, a sickle cell disease patient should have a healthy lifestyle , including proper hydration to reduce painful seizures. (carenity.co.uk)
  • Cord blood transplantation is used to treat certain genetic disorders that affect the production of blood cells, such as sickle cell anemia and thalassemia. (koruhastanesi.com)
  • The treatment for Sickle Cell Disease and other blood problems is bone marrow transplantation, carried out at BMT cost in Greater Accra Regional Hospital. (bonemarrowtransplantations.com)
Oncology2
  • Hopkins Oncology Center (JHOC), Baltimore, MD, will evaluate novel ex vivo marrow purging regimens by comparison of the effects of incubation with graded concentrations of immunologic and/or pharmacologic agents on the growth of normal marrow and leukemic cells, using an authentic animal model of human AML (the LBN hybrid rat). (arizona.edu)
  • Specialty Compared to Oncology delivered Palliative Care for Patients with Acute Myeloid Leukemia (SCOPE-Leukemia) is a cluster-randomized comparative effectiveness trial of primary palliative care versus specialty palliative care in patients with acute myeloid leukemia (AML) and their caregivers. (partners.org)
Complications5
  • However, patients with AR HIES are susceptible to viral infection characterized by severe Molluscum contagiosum and may develop severe neurological complications for unknown reasons. (medscape.com)
  • 6 Causes of early death include leukemic transformation, complications arising from progressive bone marrow failure, portal/pulmonary hypertension, infections, thrombosis and bleeding. (haematologica.org)
  • If one of the brothers and sisters is compatible, we speak about geno-identical allogeneic transplantation having the advantage of reducing the complications post-transplantation. (longdom.org)
  • Overview of Immunodeficiency Disorders Immunodeficiency disorders are associated with or predispose patients to various complications, including infections, autoimmune disorders, and lymphomas and other cancers. (msdmanuals.com)
  • Many people with these conditions have few, if any, symptoms, but complications can occur, including stroke in patients with poorly controlled disease. (ucsfhealth.org)
Acute10
  • In order to treat patients, the aggressive therapy strategy approach must always be taken for acute bacterial infections and prophylactic antibiotics. (wikipedia.org)
  • Although the disease can evolve toward acute leukemia, morbidity and mortality most frequently result from a marrow failure syndrome. (acgtfoundation.org)
  • In a newly reported study, an experimental antibody treatment largely prevented gastrointestinal acute graft versus host disease (GI-aGVHD) in the intestines of mice and non-human primates (NHPs) given a bone marrow transplant-allogeneic hematopoietic cell transplant (allo-HCT)-but without causing broad immune suppression. (genengnews.com)
  • A good day is delivering acute, detail-oriented care to pediatric patients in need of blood cancer therapies. (atriumhealth.org)
  • Patients with DBA have developed bone cancer (osteosarcoma), colon cancer, and leukemia (blood cancer called acute myeloid leukemia), among others. (orthopedicshealth.com)
  • Allogeneic BMT is used as a curative therapy for acute and chronic leukemia. (koruhastanesi.com)
  • Cord blood transplantation is used as a treatment option for acute and chronic leukemia. (koruhastanesi.com)
  • Although the incidence of acute nonlymphocytic leukemia is increased in PV, the incidence of acute leukemia in patients not exposed to chemotherapy or radiation therapy is low. (basicmedicalkey.com)
  • Interestingly, chemotherapy, including hydroxyurea, has been associated with acute leukemia in JAK2 V617F-negative stem cells in some PV patients. (basicmedicalkey.com)
  • To realize this aspect of the clinical utility of HTS, Dr. Lori Muffly has started a longitudinal study to monitor MRD status with HTS in patients with acute lymphoblastic leukemia (ALL) who receive either standard chemotherapy or transplant. (stanford.edu)
Biopsy3
Treatment29
  • Patients with thalassemia minor usually do not require any specific treatment. (medscape.com)
  • Allogenic bone-marrow transplantation (BMT) is the only known curative treatment in this disease. (wikipedia.org)
  • Except for cases in which bone marrow transplantation can be used successfully, treatment is not curative. (rxmed.com)
  • Indeed, the hematological benefit during eculizumab treatment for PNH is very heterogeneous among patients, and different response categories can be identified. (frontiersin.org)
  • Different factors contribute to residual anemia during eculizumab treatment: underlying bone marrow dysfunction, residual intravascular hemolysis and the emergence of C3-mediated extravascular hemolysis. (frontiersin.org)
  • Among his many accomplishments, he pioneered the development of curative marrow transplantation approaches for patients who lack HLA-matched siblings and dramatically expanded treatment options for all patients. (mskcc.org)
  • For example, hematopoietic stem cell transplantation (HSCT), using bone marrow or cord blood as a source of HSCs, is an established curative treatment for a broad variety of genetic, blood, and immune disorders. (parentsguidecordblood.org)
  • the time a patient lives following treatment) at three years was 21% for patients with a TP53 mutation, less than half of the 52% of patients without a TP53 mutation and was similar among different genetic subcategories of patients with a TP53 mutation. (curetoday.com)
  • However, modern myelofibrosis prognostication systems utilized in risk-adapted treatment approaches do not include bone marrow fibrosis as a prognostic variable. (haematologica.org)
  • However, better understanding of the role of increased JAK-STAT signaling [either through activating mutations ( JAK2 , MPL515L/K ) within the signaling pathway, or mutations involving CALR ], the role of deregulated pro-inflammatory cytokine expression, and the impaired bone marrow microenvironment is transforming the treatment approach for MF. (haematologica.org)
  • Personalized Molecular Medicine ® is use of genomics and patient specific information to identify optimal treatment for each patient. (invivoscribe.com)
  • Hematological treatment can involve a long and invasive process, such as bone marrow transplantation. (bvsalud.org)
  • To overcome this problem, methods of ex vivo treatment ('purging') of autologous marrow must be developed that optimally eradicate AML cells but spare normal hematopoietic stem cells. (arizona.edu)
  • His Swim Across America project aims to use RealSeqS to develop novel molecular diagnostics to reliably classify bile duct strictures, leading to correct treatment options for cholangiocarcinoma and pancreatic ductal carcinoma patients. (swimacrossamerica.org)
  • There is now an effective curative treatment, bone marrow transplantation , because it contains the cells that produce red blood cells. (carenity.co.uk)
  • When the patient presents with anemia, the usual initial treatment includes a red cell transfusion. (orthopedicshealth.com)
  • After the first year patients are started on a course of treatment with corticosteroids. (orthopedicshealth.com)
  • Red blood transfusions are used for those patients who do not respond to corticosteroid treatment. (orthopedicshealth.com)
  • The only curative treatment for the anemia of DBA is bone marrow/stem cell transplantation. (orthopedicshealth.com)
  • BMT is used in combination with chemotherapy as a treatment for multiple myeloma, a cancer that affects the plasma cells in bone marrow. (koruhastanesi.com)
  • Treatment usually involves immunosuppression with equine antithymocyte globulin and cyclosporine , or bone marrow transplantation. (merckmanuals.com)
  • Patients who aren't experiencing symptoms may not need immediate treatment but require careful monitoring. (ucsfhealth.org)
  • In order to monitor disease after a curative treatment such as allogeneic transplant, pioneer works from Drs. David Miklos and Wen-Kai Weng have established the utility of high-throughput sequencing (HTS) of either B-cell receptor (BCR) or T-cell receptor (TCR) in monitoring minimal residual disease (MRD). (stanford.edu)
  • Historically, patients with this debilitating disease have had limited treatment options, and disease-modifying agents were not available. (cancernetwork.com)
  • Treatment selection takes into account patient age, fitness, and whether autologous stem cell transplantation (ASCT) is planned. (medscape.com)
  • A trial looking at the effectiveness of a treatment made from donated stool samples to see if gut bacteria can be increased in patients having a transplant for blood cancer. (who.int)
  • To date, there is no curative treatment for sarcoidosis, but only anti-inflammatory drugs limiting the pathologic impact of sarcoidosis in reducing enhanced immunity reactions, granulomatous formation, and their consequences. (medscape.com)
  • The risks for sarcoidosis treatment vary from patient to patient. (medscape.com)
  • Corticosteroids remain the cornerstone for the treatment of sarcoidosis particularly at induction with a rapid response in most patients and the potential occurrence of adverse events. (medscape.com)
Hematopoietic cell transplantation2
Therapeutic2
  • Hematopoietic stem cell transplantation remains the only curative therapeutic approach that reliably results in resolution of bone marrow fibrosis in patients with myelofibrosis. (haematologica.org)
  • However, the presence of residual occult viable leukemic cells in the marrow autograft limits the therapeutic effectiveness of ABMT in AML. (arizona.edu)
Peripheral blood4
Severe7
  • 3, 4] In addition, tyrosine kinase 2 deficiency (tyk2) deficiency was reported in patients with HIES, but tyk2 deficiency is also characterized by severe viral and bacterial infections. (medscape.com)
  • Between 2009 and 2017, results translated into a phase I-II trial for adults with severe SCD not eligible for other curative therapies and with severe organ damage. (nih.gov)
  • Stopping rules were built into the study so that if too many patients either rejected their grafts or developed moderate to severe GVHD, the study would move to the 2nd cohort. (nih.gov)
  • Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematological disorder characterized by complement-mediated intravascular hemolysis, bone marrow failure, and severe thrombophilia ( 1 ). (frontiersin.org)
  • Patients with MPN may have moderate or severe anemia, a condition where there are not enough red blood cells to carry oxygen. (ucsfhealth.org)
  • The symptoms of hepatic encephalopathy may range from mild to severe and may be observed in as many as 70% of patients with cirrhosis. (medscape.com)
  • However, in some patients, this disease may also be life-threatening, particularly when severe manifestations induce vital organ dysfunction. (medscape.com)
HSCT5
  • Our findings suggest the superiority of FM140 in patients with MDS undergoing allo-HSCT, especially in high-risk patients. (bvsalud.org)
  • In recent years, especially after the advent of reduced intensity conditioning in the late 1990s, allogeneic HSCT is increasingly used in older patients and as an effective salvage strategy for patients with lymphoma or myeloma not responding to chemotherapy or autologous HSCT. (longdom.org)
  • Allogeneic hemopoietic stem cell transplantation (HSCT) is the only curative option for many patients with hematological malignancies. (nih.gov)
  • Since many of these patients lack HLA-identical sibling donors and are older or have comorbidity, a fully ablative HSCT is not feasible and an alternative approach is required. (nih.gov)
  • Hence the outcome of reduced intensity HSCT with lymphodepleting antibodies in older patients with intermediate/high-risk hematological malignancies appears comparable to that obtained with fully ablative transplantation in younger patients, even when these older recipients lack HLA-identical sibling donors. (nih.gov)
Platelets5
  • [17] Less commonly, the disease comes to light only after the cancerous cells overwhelm the bone marrow, resulting in low red blood cells, neutrophils, or platelets. (wikipedia.org)
  • Bone marrow is the place for the production of the hematopoietic cells which differentiate in to three groups: red blood cells, white blood cells and platelets. (longdom.org)
  • The pathognomonic characteristic of HPS is the activation of well-differentiated macrophages, phagocyting erythrocytes, leukocytes and platelets in bone marrow, lymph nodes, spleen, liver and other organs, which can infiltrate almost anybody district and may account for many of its systemic features [ 3 ]. (biomedcentral.com)
  • Aplastic anemia is a disorder of the hematopoietic stem cell that results in a loss of blood cell precursors, hypoplasia or aplasia of bone marrow, and cytopenias in two or more cell lines (red blood cells, white blood cells, and/or platelets). (merckmanuals.com)
  • Thrombopoietin helps control the number of circulating platelets by stimulating the bone marrow to produce megakaryocytes. (merckmanuals.com)
Cytopenias4
  • Patients with MDS typically are diagnosed when they are in their 70s, have significant cytopenias, and have substantive transfusion needs. (jnccn.org)
  • The term aplastic anemia commonly implies a panhypoplasia of the bone marrow with cytopenias in at least two hematopoietic lineages. (merckmanuals.com)
  • The clinical course of individuals with MF is heterogeneous and characterized by constitutional symptoms, bone marrow myeloproliferation and fibrosis, progressive cytopenias, and symptomatic splenomegaly. (cancernetwork.com)
  • The clinical course of individuals with MF is characterized by constitutional symptoms (fevers, night sweats, and weight loss), bone marrow myeloproliferation and reticulin/collagen fibrosis, worsening cytopenias, thrombosis, and progressive symptomatic splenomegaly. (cancernetwork.com)
Disorders7
  • The myelodysplastic syndromes (MDS) are a group of clonal neoplastic hematologic disorders characterized by varying degrees of bone marrow failure, abnormal hematopoiesis, and proliferation of myeloid blast cells. (acgtfoundation.org)
  • Currently ~60% of patients with congenital anaemia remain without a genetic diagnosis and part of my research utilises next generation sequencing technologies to identify novel causative variants and broaden the diagnostic range for these disorders. (ox.ac.uk)
  • The Koru Hospital Bone Marrow Transplant Center is a state-of-the-art medical facility that offers advanced stem cell therapy for a range of hematological disorders. (koruhastanesi.com)
  • Allogeneic BMT is used as a curative therapy for MDS, a group of disorders that affect the production of blood cells in bone marrow. (koruhastanesi.com)
  • Myeloproliferative neoplasms, or MPNs - also called myeloproliferative disorders, or MPDs - are a collection of blood disorders that are believed to be caused by mutations in bone marrow stem cells. (ucsfhealth.org)
  • The discovery of an activating point mutation in the Janus kinase 2 gene ( JAK2 V617F) in a significant portion of patients with MPNs led to improved understanding of the pathobiology of these disorders and prompted rapid development of JAK inhibitors. (cancernetwork.com)
  • bone marrow analysis differentiates classic PNH from PNH secondary to other bone marrow disorders. (medscape.com)
Cord blood1
Myelodysplastic4
  • T he first description of patients with a blood picture compatible with the myelodysplastic syndromes (MDS) was published at the beginning of the 20th century, 1 and the first MDS case series was published in the early 1970s. (jnccn.org)
  • It was described as "the only curative therapy for myelodysplastic syndrome" in a 2016 study published in Hematology, ASH Education Program . (curetoday.com)
  • The patients are also at risk for a pre-leukemic syndrome called myelodysplastic syndrome which is another disorder caused by the bone marrow not making enough healthy blood cells. (orthopedicshealth.com)
  • 15]. The percentage of bone common of which are trisomy 8, mono- marrow blast cells for estimation of the Myelodysplastic syndrome (MDS) is somy 7 and 5q- [11]. (who.int)
Abnormal5
Blood and marrow3
  • The latest study findings were reached via genetic analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 multicenter study of comparing different therapy options among 309 patients with MDS ages 50 to 75 with International Prognostic Scoring System (IPSS) intermediate-2 or high-risk MDS. (curetoday.com)
  • Dr. Eckrich also received a master's degree in public health and completed fellowships at Vanderbilt University and the Center for International Blood and Marrow Transplant (CIBMTR) at the Medical College of Wisconsin. (atriumhealth.org)
  • Methods Center for International Blood and Marrow Transplant Research data from 184 adults who completed the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) before undergoing alloHCT and at day 100 were used. (cdc.gov)
Lymph nodes1
Clinical14
  • Patients in whom the clinical severity of the disease lies between that of thalassemia major and thalassemia minor are categorized as having thalassemia intermedia . (medscape.com)
  • Buckley et al expanded the clinical picture in 1972 and reported the association with elevated immunoglobulin E (IgE) in patients with hyperimmunoglobulin E syndrome. (medscape.com)
  • Patients with receptor defects of IFN-γ or IL-12 have disseminated atypical mycobacterial infections with incomplete granuloma formation and do not exhibit clinical features of HIES. (medscape.com)
  • This is not surprising as there are well-accepted clinical and morphologic differences between pediatric and adult MDS (e.g., bone marrow hypocellularity is more common in children) leading the World Health Organization (WHO) to classify MDS differently in adults and in children 10 . (nature.com)
  • Although being proposed with curative intentions, clinical intercurrences cause impacts on the individual's physical, psychological and emotional health. (bvsalud.org)
  • The great advances made in basic and clinical immunology in the recent decades and the rise in the number of patients with asthma and allergies necessitated the establishment of a research center in Iran to encourage clinical and basic researches in the above fields. (educationiran.com)
  • AUCRC/JHOC studies of clinical ABMT in patients with AML. (arizona.edu)
  • Interested patients may have the option to participate in clinical trials of potential new therapies. (ucsfhealth.org)
  • First, given the utmost patient specificity and sensiyivity, it can be used to predict clinical outcome after allogeneic transplantation. (stanford.edu)
  • Even in patients who were in complete clinical remission (no detectable disease by physical examination, flow cytometry, imaging study), persistent MRD detected by HTS translated to a much higher chance of eventual disease relapse, compared to achieving molecular remission (84% chance versus 17% chance of relapse). (stanford.edu)
  • Most importantly, it will help to shed light on whether intervenNon(s) based on MRD status will have a positive clinical impact on this patient population. (stanford.edu)
  • Bringing cuttng-edge technology to daily clinical patient care has been one of the research hallmarks of the Stanford BMT program. (stanford.edu)
  • In the current study, the authors investigated whether patients expressed regret after undergoing HCT and the relationships between clinical outcomes and quality of life. (cdc.gov)
  • 6. Patients with a concurrent active malignancy or a prior malignancy, except lobular breast carcinoma in situ, fully resected basal cell or squamous cell carcinoma of the skin or treated cervical carcinoma in situ, an incidental histologic finding of prostate cancer (T1a or T1b using the tumour, node, metastasis (TNM) clinical staging system), previous MDS, CMML, MPN resulting in secondary AML. (who.int)
Hematological1
  • Complete normalization of hemoglobin (complete and major hematological response), is seen in no more than one third of patients, while the remaining continue to experience some degree of anemia (good and partial hematological responses), in some cases requiring regular red blood cell transfusions (minor hematological response). (frontiersin.org)
Lymphoma5
  • Our center provides personalized, compassionate care to patients with leukemia, lymphoma, multiple myeloma, and other blood-related conditions. (koruhastanesi.com)
  • Autologous BMT is used as a salvage therapy for patients with relapsed or refractory Hodgkin's lymphoma. (koruhastanesi.com)
  • Autologous BMT is used as a consolidation therapy for patients with high-risk non-Hodgkin's lymphoma. (koruhastanesi.com)
  • In one such example, HTS was used to measure the patient-specific TCR sequences in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) after a non-myeloablative allogeneic transplant. (stanford.edu)
  • Patients present a deficient natural killer cell activity, susceptibility to malignant lymphoma, and the presence of large intracytoplasmic granulations in various cell types. (lu.se)
Diagnosis2
  • Bone marrow studies are necessary to confirm the diagnosis. (rxmed.com)
  • U.S. clinicians need to consider a malaria diagnosis in patients with unexplained fever, especially in areas where autochthonous malaria has been recently reported, although the risk for autochthonous malaria in the United States remains very low. (cdc.gov)
Aspiration1
  • Bone marrow aspiration is carried out by a puncture on the level of the sternum or the posterior iliac peaks under local anesthesia by the doctor. (longdom.org)
Transplants5
Patient's1
Malignant and non-malignant1
  • Although bone marrow fibrosis is seen in a variety of malignant and non-malignant disease states, the deposition of reticulin and collagen fibrosis in the bone marrow of patients with myelofibrosis is believed to be mediated by the myelofibrosis hematopoietic stem/progenitor cell, contributing to an impaired microenvironment favoring malignant over normal hematopoiesis. (haematologica.org)
Relapse1
  • Patients who achieved molecular remission had less chance of disease relapse than those who had detectable MRD (13% chance versus 92% chance of relapse). (stanford.edu)
Diseases3
  • The only curative therapy for T-lymphocyte defects and genetic diseases is the replacement of the normal lymphocyte stem cells. (twoday.net)
  • Nevertheless, MDS are thought to be immunologically responsive diseases, as immunomodulatory drugs can induce remissions, and allogeneic bone marrow transplantation can be curative in the small fraction of patients for whom this is an option. (acgtfoundation.org)
  • This platform provides us with an opportunity to create therapies that could redefine standards of care for patients with life-threatening diseases. (seekingalpha.com)
Mutations5
  • however, some patients have AD HIES-like disease without STAT3 mutations. (medscape.com)
  • 7] Some patients with AR HIES have mutations in DOCK8. (medscape.com)
  • Multiple large cohort studies of adult MDS patients found recurrent mutations in genes important in epigenetic regulation (e.g. (nature.com)
  • We show that Ras/MAPK pathway mutations are common in pediatric primary MDS (45%) while mutations in RNA splicing genes are rare (2%), and that germline SAMD9/SAMD9L mutations are present in 17% of primary MDS patients. (nature.com)
  • The molecular causes of the majority of MPN cases have been identified - mutations in the genes JAK2 and ABL are found in nearly all patients with polycythemia vera and chronic myeloid leukemia, respectively. (ucsfhealth.org)
Malignancies1
20161
  • In another paper, the cumulative survival in 150 adults was followed from 2003 to 2016 and patients were screened for heart, lung, and kidney disease. (nih.gov)
Spleen1
  • Patients with chronic myelogenous leukemia and myelofibrosis often feel tired and report pain or fullness in their belly from an enlarged spleen. (ucsfhealth.org)
Regimens1
  • [ 2 ] Options for second-line therapy in patients with relapsed/refractory disease include chemotherapy-free regimens with biologic targeted agents such as covalent Bruton tyrosine kinase (BTK) inhibitors, lenalidomide,venetoclax, and chimeric antigen receptor (CAR) T-cell therapy. (medscape.com)
Myelofibrosis6
  • Bone marrow fibrosis is a central pathological feature and World Health Organization major diagnostic criterion of myelofibrosis. (haematologica.org)
  • The specific effect on bone marrow fibrosis of JAK2 inhibition, and other rationally based therapies currently being evaluated in myelofibrosis, has yet to be fully elucidated. (haematologica.org)
  • In approximately 15% of patients, however, myelofibrosis is accompanied by significant extramedullary hematopoiesis, hepatosplenomegaly, and transfusion-dependent anemia, which are manifestations of stem cell failure. (basicmedicalkey.com)
  • MPNs can sometimes transform to leukemia or to myelofibrosis, an MPN that is characterized by excessive scar-type tissue in the bone marrow. (ucsfhealth.org)
  • Testoterone therapy can sometimes improve anemia in patients with myelofibrosis. (ucsfhealth.org)
  • In this article, we provide updated data on ruxolitinib therapy for patients with myelofibrosis and offer expert opinion on the appropriate use of this agent in the community practice. (cancernetwork.com)
Transplant center2
  • As we continue to advance omidubicel for a potential launch and prepare to become a commercial organization, we are establishing key commercial capabilities, including the creation of Gamida Cell Assist a program designed to support a positive patient and transplant center experience. (seekingalpha.com)
  • At the Koru Hospital Bone Marrow Transplant Center, we provide comprehensive care to our patients, from pre-transplant evaluation to post-transplant follow-up care. (koruhastanesi.com)
Abnormalities2
  • 12] Studies in toll-like receptor (TLR)-mediated signaling in patients with HIES did not reveal anty abnormalities either. (medscape.com)
  • About 50% of these patients have had T-cell abnormalities. (twoday.net)
Prognostic3
  • A number of studies indicate that bone marrow fibrosis is an adverse prognostic variable in myeloproliferative neoplasms. (haematologica.org)
  • Here we review the pathogenesis, biological consequences, and prognostic impact of bone marrow fibrosis. (haematologica.org)
  • Develop strategies to promote effective coping and enhance illness and prognostic understanding in patients with AML. (partners.org)
Reliably1
  • Reliably curative treatments for MCL are lacking. (medscape.com)
Thrombosis1
  • PNH usually presents as hemolytic anemia, thrombosis, and smooth muscle dystonias, as well as bone marrow failure in some cases. (medscape.com)
Anemia3
  • Blackfan-Diamond anemia (BDA) is a rare blood disorder that is caused by a failure of the bone marrow to generate enough red blood cells. (orthopedicshealth.com)
  • Of course, in patients with associated acid-peptic disease, occult gastrointestinal bleeding may lead to a presentation with hypochromic, microcytic anemia, masking the presence of PV. (basicmedicalkey.com)
  • Aplastic anemia is suspected in patients, particularly young patients, with pancytopenia. (merckmanuals.com)
Remission3
  • Hudroxyurea and other myelosuppressive drugs help to keep the patient in remission, by keeping the white cell count under 50,000. (rxmed.com)
  • Recently, Interferon Alpha has been shown to normalize the bone marrow, and bring about remission. (rxmed.com)
  • Approximately 50% of the patients achieved molecular remission in both skin and blood compartments after allogeneic transplant while the other 50% had persistent MRD detected by HTS. (stanford.edu)
Cancer7
  • Dr. O'Reilly, Chairman of the Department of Pediatrics and Director of the Bone Marrow Transplantation Program at MSK, has been a thought leader in pediatric cancer care for his four-decade career. (mskcc.org)
  • Chronic lymphocytic leukemia ( CLL ) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell ). (wikipedia.org)
  • For her recently approved SAA grant, Dr. Smith proposes to develop a next-generation MANAFEST platform and test its implementation in patients with lung cancer. (swimacrossamerica.org)
  • While the biospecimens used in this study are from lung cancer patients, if successful, this assay will have broad applicability to all tumor types for which antigen-specific TCRs can be studied. (swimacrossamerica.org)
  • It is a patient-centered, evidence-based field of supportive cancer care that utilizes integrative therapies such as mind-body practices, acupuncture, massage, music therapy, nutrition, and exercise in collaboration with conventional cancer treatments. (isncc.org)
  • Once the unique rearranged CDR3 sequences of these receptor (the cancer clonotype) were identified, these patient-specific cancer clonotype(s) were used to measure paNent's disease in a highly-specific, sensitive and quantitative manner using HTS. (stanford.edu)
  • Cancer treated with curative intent = 5 years previously will be allowed. (who.int)
Symptoms6
  • patients identified have no symptoms. (unboundmedicine.com)
  • Manage the physical and psychological symptoms experienced by patients with AML. (partners.org)
  • Demonstrate effective management of physical and psychological symptoms experienced by patients with AML. (partners.org)
  • These patients generally do not have any symptoms. (carenity.co.uk)
  • Some of the central nervous system symptoms observed in patients with PV, such as ocular migraine, appear to represent a variant of erythromelalgia. (basicmedicalkey.com)
  • While not a curative option, ruxolitinib offers great palliative potential and results in significant reduction in splenomegaly and improvement in constitutional symptoms in the majority of treated patients, thus improving their quality of life and performance status. (cancernetwork.com)
Therapy4
  • Bone-marrow transplantation is the primary therapy for T-lymphocyte defects. (twoday.net)
  • Bone-marrow therapy may have a future role for patients with AIDS and/or other T-helper cell deficiencies. (twoday.net)
  • 2020 was an important year for Gamida Cell as we made significant progress across our entire pipeline, including omidubicel, which is poised to become the first FDA approved cell therapy for bone marrow transplantation. (seekingalpha.com)
  • If the patient remains on chronic transfusion therapy (usually required every 3-4 weeks) then the patient will also require iron chelation. (orthopedicshealth.com)
Laboratory2
  • The Laboratory for Personalized Molecular Medicine ® (LabPMM ® ) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care. (invivoscribe.com)
  • An elevated arterial or free venous serum ammonia level is the classic laboratory abnormality reported in patients with hepatic encephalopathy. (medscape.com)
Treatments3
  • Despite the high potential and over 200 years of experience with cell therapies, the number of available cellular treatments and their beneficial impact on patients are limited. (parentsguidecordblood.org)
  • In this model, treatments can be evaluated initially as single agents for their activity in GVHD prophylaxis, unlike in human patients, where new interventions must be combined with drugs used for routine GVHD prevention. (genengnews.com)
  • Although myeloproliferative neoplasms usually cannot be cured, there are treatments for all patients with the condition. (ucsfhealth.org)
Stem cell3
  • The team confirmed that the Notch pathway involvement in GVHD was conserved across species, and demonstrated in their animal models that just a single dose of the DLL4-blocking antibody given immediately before stem cell transplantation greatly increased survival and prevented signs of GVHD in the intestines, but without causing global immunosuppression. (genengnews.com)
  • Sometimes stem cell transplantation is curative. (msdmanuals.com)
  • The essence of MDS is damage of In the current work we examined All our patients were of the high-risk colony-forming units [4], but the defect haematopoietic stem cells of high-risk group and none of them was eligible of the haematopoietic stem cells is not MDS cases for apoptotic and anti-apop- for stem cell transplantation. (who.int)
Reticulin1
  • Bone marrow fibrosis (BMF) is characterized by the increased deposition of reticulin fibers and in some cases collagen fibers. (haematologica.org)
100,0002
  • As one would expect of a disease primarily affecting older adults, incidence rates were lowest for people younger than 40 years, at 0.14 per 100,000, and highest with increasing age, reaching a level of 36 per 100,000 for patients aged 80 years and older. (jnccn.org)
  • Hematopoietic stem cells (HSCs) are very rare cells, representing approximately one in 100,000 bone marrow (BM) cells in the adult. (longdom.org)
Cells13
  • Surprisingly, germline variants in SAMD9 or SAMD9L were present in 17% of primary MDS patients, and these variants were routinely lost in the tumor cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH). (nature.com)
  • Evidence exists that immune activation against hematopoietic elements frequently occurs in MDS patients, based on the identification of lymphocytic infiltrates in the marrow, oligoclonal expansion of T cells, and excessive production of tumor necrosis factor alpha. (acgtfoundation.org)
  • Viable cells have short shelf-life at ambient temperatures that complicates their storage and delivery to patients. (parentsguidecordblood.org)
  • [18] Whereas, with CLL, diseased cells propagate from within the bone marrow, in SLL they propagate from within the lymphatic tissue. (wikipedia.org)
  • Normal plasma cells are found in the bone marrow and are an important part of the immune system. (invivoscribe.com)
  • a bone marrow smear is examined for giant inclusion bodies in leukocyte precursor cells. (msdmanuals.com)
  • The primary endpoint of the study was time to neutrophil engraftment, or the time it took for the white blood cells to recover following transplantation. (seekingalpha.com)
  • Anaemia results from the failure of adequate production of red blood cells in the bone marrow or insufficient production of the oxygen carrying metalloprotein haemoglobin. (ox.ac.uk)
  • CFU-Leuk), which we have shown are predictive for hematopoietic engraftment and AML log-kill in rats given syngeneic marrow and/or AML cells incubated ex vivo with selected chemotherapeutic agents, will be used in these dose-response studies. (arizona.edu)
  • and re-introducing the cells back into the patient. (sanfranciscostar.com)
  • This would involve introducing a functional hemoglobin gene into the bone marrow stem cells of affected patients so that the hemoglobin produced is once again functional. (carenity.co.uk)
  • Your blood or bone marrow is harvested for stem cells, which are then frozen. (bonemarrowtransplantations.com)
  • All patients can evolve into trisomy 8+ MDS [12], cells, since acquiring adequate samples diagnosed with MDS have a reduced in which 8+ appears to confer a favour- for flow cytometric analysis renders the life expectancy compared with age- able prognosis [13]. (who.int)
Survival4
  • In a publication on 225 patients, primarily with Hb SS disease, data shows that even though 60% of patients were taking hydroxyurea, the median survival age was only 48 years. (nih.gov)
  • 5 4 In addition to increased disease-related morbidity, MF results in early death with the median survival of affected patients being approximately 6 years. (haematologica.org)
  • Recent findings In select patients, disease-free and overall survival is greater than 80% following matched sibling BMT for SCD. (johnshopkins.edu)
  • Additionally, ruxolitinib is the only agent that has demonstrated a survival benefit in patients with MF. (cancernetwork.com)